Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Dietrich C. Gulba"'
Autor:
Tom Stargardt, Hans-Peter Lipp, Peter J. Kuhlencordt, Thomas-Maria Helms, Dietrich C. Gulba, Johannes Hankowitz, Peter Bramlage, Ingo Ahrens, Sigrid Nikol, Hanno Riess, Andreas Schäfer
Publikováno v:
DMW - Deutsche Medizinische Wochenschrift. 142:986-993
ZusammenfassungMit der kürzlich erfolgten Zulassung des vierten direkten, neuen nicht-Vitamin-K-abhängigen oralen Antikoagulans (NOAK) Edoxaban hat sich die Palette der verfügbaren NOAKs zur Therapie der venösen Thromboembolie (VTE) erweitert. Ku
Autor:
Jose Lopez-Sendon, Shaun G. Goodman, Dietrich C. Gulba, Gilles Montalescot, Enrique P. Gurfinkel, Joel M. Gore, Christopher B. Granger, David Brieger, Sami Alnasser, Kim A. Eagle, Werner Klein, Brian M. Kennelly, Wei Huang, Andrzej Budaj, Frederick A. Anderson, Alvaro Avezum, Robert J. Goldberg, Phillippe Gabriel Steg, Frans Van de Werf, Keith A.A. Fox, Emily Fleming
Publikováno v:
The American Journal of Medicine. 128:766-775
Purpose Short-term outcomes have been well characterized in acute coronary syndromes; however, longer-term follow-up for the entire spectrum of these patients, including ST-segment-elevation myocardial infarction, non-ST-segment-elevation myocardial
Autor:
Jurriën M. ten Berg, Angel Lanas, Gregory Y.H. Lip, Gemma Vilahur, Dirk Sibbing, Rustam Al-Shahi Salman, Freek W.A. Verheugt, Jean-Philippe Collet, Steen Husted, Robert F. Storey, Sigrun Halvorsen, Felicita Andreotti, Kurt Huber, João Morais, Dietrich C. Gulba, Thomas W. Weiss, Erik Lerkevang Grove, Philippe Gabriel Steg, Bianca Rocca
Publikováno v:
Halvorsen, S, Storey, R F, Rocca, B, Sibbing, D, Ten Berg, J, Grove, E L, Weiss, T W, Collet, J-P, Andreotti, F, Gulba, D C, Lip, G Y H, Husted, S, Vilahur, G, Morais, J, Verheugt, F W A, Lanas, A, Al-Shahi Salman, R, Steg, P G, Huber, K & ESC Working Group on Thrombosis 2017, ' Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation : expert consensus paper of the European Society of Cardiology Working Group on Thrombosis ', European Heart Journal, vol. 38, no. 19, pp. 1455-1462 . https://doi.org/10.1093/eurheartj/ehw454
Halvorsen, S, Storey, R F, Rocca, B, Sibbing, D, Ten Berg, J, Grove, E L, Weiss, T W, Collet, J-P, Andreotti, F, Gulba, D C, Lip, G Y H, Husted, S, Vilahur, G, Morais, J, Verheugt, F W A, Lanas, A, Al-Shahi Salman, R, Steg, P G, Huber, K & ESC Working Group on Thrombosis 2017, ' Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation : expert consensus paper of the European Society of Cardiology Working Group on Thrombosis ', European Heart Journal, vol. 38, no. 19, ehw454, pp. 1455-1462 . https://doi.org/10.1093/eurheartj/ehw454
EUROPEAN HEART JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Heart Journal, 38, 19, pp. 1455-1462
European Heart Journal, 38, 1455-1462
Halvorsen, S, Storey, R F, Rocca, B, Sibbing, D, Ten Berg, J, Grove, E L, Weiss, T W, Collet, J-P, Andreotti, F, Gulba, D C, Lip, G Y H, Husted, S, Vilahur, G, Morais, J, Verheugt, F W A, Lanas, A, Al-Shahi Salman, R, Steg, P G, Huber, K & ESC Working Group on Thrombosis 2017, ' Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation : expert consensus paper of the European Society of Cardiology Working Group on Thrombosis ', European Heart Journal, vol. 38, no. 19, ehw454, pp. 1455-1462 . https://doi.org/10.1093/eurheartj/ehw454
EUROPEAN HEART JOURNAL
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Heart Journal, 38, 19, pp. 1455-1462
European Heart Journal, 38, 1455-1462
Bleeding is a frequent complication of the management of patients with coronary artery disease (CAD), especially those presenting with acute coronary syndromes (ACS) or undergoing percutaneous coronary intervention (PCI), and of patients with atrial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b92a700b2a3e6064ff7c4f8f7bc7f459
https://pure.au.dk/portal/da/publications/management-of-antithrombotic-therapy-after-bleeding-in-patients-with-coronary-artery-disease-andor-atrial-fibrillation(733ddb37-9aed-47a7-96bc-c0691b475d61).html
https://pure.au.dk/portal/da/publications/management-of-antithrombotic-therapy-after-bleeding-in-patients-with-coronary-artery-disease-andor-atrial-fibrillation(733ddb37-9aed-47a7-96bc-c0691b475d61).html
Autor:
Laurent Bonello, Dirk Sibbing, Róbert Gábor Kiss, Dietmar Trenk, Kurt Huber, András Komócsi, Dietrich C. Gulba, Daniel Aradi, Jean-Philippe Collet, Robert F. Storey, Steen Husted
Publikováno v:
European Heart Journal
Optimizing outcomes after percutaneous coronary intervention (PCI) requires balancing between the risks of thrombotic and bleeding events in individual patients.1–3 However, finding the optimal balance is not always straightforward since the risks
Publikováno v:
Der Klinikarzt. 42:34-39
Elektive operative Eingriffe stellen bei Patienten mit bestehender Antikoagulantien-Dauertherapie eine besondere Herausforderung dar, da sie mit einem erhohten thromboembolischen Risiko assoziiert sind. Fur die Vitamin-K-Antagonisten, die bereits sei
Autor:
Gilles Montalescot, Ann L. Quill, Allison Wyman, Joel M. Gore, Alvaro Alonso, Frans Van de Werf, Keith A.A. Fox, Ph. Gabriel Steg, Christopher B. Granger, Hamza H. Awad, Dietrich C. Gulba, Kim A. Eagle
Publikováno v:
European Heart Journal: Acute Cardiovascular Care. 2:280-291
To describe the characteristics, treatment, and mortality in patients with ST-elevation myocardial infarction (STEMI) by use of chronic oral anticoagulant (OAC) therapy.Using data from the Global Registry of Acute Coronary Syndromes (GRACE), patient
Publikováno v:
Der Klinikarzt. 40:24-27
Die neue Leitlinie der Europaischen Gesellschaft fur Kardiologie (ESC) zum Vorhofflimmern legt besonderen Wert auf die Effektivitat der Antikoagulation zur Verhinderung von Schlaganfallen und systemischen Thombembolien. Wegen des empfohlenen CHA 2 DS
Autor:
Nawwar Al-Attar, Carina Blomström-Lundqvist, Michael Weis, Frank V. Aguirre, Frans Van de Werf, Keith A.A. Fox, Dariusz Dudek, Keith McGregor, Sigmund Silber, Amadeo Betriu, Eduardo Alegría, Adnan Kastrati, Annika Rosengren, Carlo Di Mario, Udo Sechtem, Gerasimos Filippatos, Werner Benzer, Freek W.A. Verheugt, Kurt Huber, José Luis Zamorano, Alec Vahanian, Steen Dalby Kristensen, Petr Widimsky, Kenneth Dickstein, Jeroen J. Bax, Ole A. Breithardt, Sigrun Halvorsen, Michal Tendera, Veronica Dean, Filippo Crea, Nicholas Danchin, Gregory Y.H. Lip, Raffaele De Caterina, P. Gabriel Steg, Dietrich C. Gulba, Philipp A. Kaufmann, Felicita Andreotti, Frans H. Rutten, Franz Weidinger, Volkmar Falk, Irene Hellemans, Christian Funck-Brentano, Marco Tubaro, Ran Kornowski, John Camm
Publikováno v:
European Heart Journal. 29:2909-2945
Guidelines and Expert Consensus Documents summarize and evaluate all currently available evidence on a particular issue with the aim of assisting physicians in selecting the best management strategies for a typical patient, suffering from a given con
Autor:
Dietrich C. Gulba, Elliott M. Antman, Neal S. Kleiman, Shaun G. Goodman, Pierluigi Tricoci, Yuliya Lokhnygina, Anatoly Langer, James J. Ferguson, Steven R. Steinhubl, Robert M. Califf, Philip E. Aylward, Robert A. Harrington, Lisa G. Berdan, L. Kristin Newby, Kenneth W. Mahaffey, Harvey D. White
Publikováno v:
Circulation. 116:2669-2677
Background— Optimal timing for an early invasive strategy in patients with non–ST-segment–elevation acute coronary syndrome remains unclear. We evaluated the relationship between time from hospital admission to coronary angiography and outcomes
Autor:
Basil S. Lewis, Nathan Roguin, C. Michael Gibson, ExTRACT-TIMI Investigators, Marc Cohen, Eugene Braunwald, Dietrich C. Gulba, Oscar H. Kracoff, Sabina A. Murphy, Diego Ardissino, Gilles Montalescot, Elliott M. Antman, David A. Morrow
Publikováno v:
Journal of the American College of Cardiology. 49(23):2238-2246
ObjectivesWe sought to evaluate whether enoxaparin (ENOX) is superior to unfractionated heparin (UFH) as adjunctive therapy for patients with ST-segment elevation myocardial infarction (STEMI) who receive fibrinolytic therapy and subsequently undergo